Licensed Patent Rights. Subject to [Section 10.1.3], Enanta, acting through patent counsel or agents of its choice, shall be solely responsible, at its sole cost and expense, for the preparation, filing, prosecution and maintenance of the Licensed Patent Rights. In accordance with [Section 10.1.5], Enanta will collaborate with Abbott on the preparation, filing and prosecution of the Licensed Patent Rights worldwide by providing Abbott with copies of any substantive office actions and setting up meetings with respective Patent Coordinators to discuss strategies and responses.

Licensed Rights. All licenses and rights granted to [[Savara:Organization]], under this Agreement, including, but not limited to the license described in 2.1(a), shall be deemed fully paid, perpetual, and irrevocable.

Licensed Patent Rights. Both Abbott and Enanta shall have the unilateral right to enforce any and all Licensed Patent Rights on any Product following the First Commercial Sale of such Product. All costs, including, without limitation, attorneys’ fees, relating to such legal proceedings or other action shall be borne by the party enforcing such rights. In the event such an Infringement relates to any Licensed Patent Rights on any Compound, Candidate or Product prior to the First Commercial Sale of such Product, Enanta shall have the first right (not the obligation) to enforce such claim with respect to such Infringement. All costs, including, without limitation, attorneys’ fees, relating to such legal proceedings or other action shall be borne by Enanta. If Enanta does not take or initiate commercially reasonable steps to initiate legal proceedings or take other actions regarding the Infringement within # twenty (20) days from any Infringement Notice in the case of an Infringement resulting from the submission by any Third Party of an abbreviated new drug application under the Hatch-Waxman Act, and # one hundred twenty (120) days from any Infringement Notice that relates to any other Licensed Patent Rights, then Abbott shall have the right and option to do so at its expense; provided, that Abbott shall not admit the invalidity or unenforceability of any such Licensed Patent Rights without Enanta’s prior written consent.

Licensed Rights. All licenses and rights granted to [[Savara:Organization]], under this Agreement, including, but not limited to the license described in Section 2.1(a), shall immediately terminate (except to the extent necessary to allow [[Savara:Organization]] to sell off its inventory pursuant to [Section 12.7(b)(i)]). [[Grifols:Organization]], in its sole discretion, may elect to assume or terminate any sublicenses granted by [[Savara:Organization]] pursuant to Section 2.2 (to the extent offered by [[Savara:Organization]] and assignable).

As between the Parties, CANbridge will have the ​ and LogicBio will have the ​. The Parties will ​ in Prosecuting LogicBio Licensed Patent Rights, and ​.

Licensed Rights. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee an exclusive license to use the trademarks (the “Licensed Property”) on or in connection with the manufacture, sale, distribution, marketing, advertising and other related activities of the goods and/or services (“Licensed Products”) solely for the period (the “License Period”) in the territory (the “Licensed Territory”), subject to Licensee’s payment of the Royalty (“Royalty”), each as set forth in the License Schedule. Also during the Licensed Period, Licensor shall grant to Licensee an exclusive license to any recipe or formulation used to manufacture the Licensed Products in the Licensed Territory. For purposes of this agreement, accessories and other goods (including those used in association with cannabis) in any form bearing the Licensed Property (“Licensed Accessories”) are distinct from Licensed Products, and Licensee shall seek the prior approval of Licensor before using the Licensed Property in connection with such Licensed Accessories. Licensor may grant a license for Licensed Accessories at its sole discretion (including defining the territory and whether such license is exclusive). Unless specifically noted in an approval, for Licensed Accessories approved by Licensor, all terms of this Agreement shall apply.

(i) ​ If [[FibroGen:Organization]] declines to file for, prosecute, or maintain (including defending or prosecuting office actions, prosecutions or interferences) any Licensed Patent Right in the Territory, then it will give HFB reasonable notice thereof and thereafter, HFB may, upon written notice to [[FibroGen:Organization]] and at HFB’s sole cost, control the filing for, prosecution and maintenance of such Licensed Patent Right in the Territory thereafter in accordance with this [Section 9.3(e)(i)] (Licensed Technology), mutatis mutandis.

Challenges to Licensed Patent Rights. Neither [[Organization A:Organization]] nor any of its Affiliates or Sublicensees shall institute or actively participate as an adverse party in, or otherwise provide material support to, any legal action or administrative proceeding in the Territory to invalidate or limit the scope of any Licensed Patent Right claim or obtain a ruling that any Licensed Patent Right claim is unenforceable or not patentable or that any Licensed Product does not infringe one or more claims of any Licensed Patent Right (“Licensed Patent Right Challenge”) until the expiration of eighty (80) Business Days after [[Organization A:Organization]] serves on [[Agenus:Organization]] written notice of [[Organization A:Organization]]’s or any [[Organization A:Organization]] Affiliate’s or Sublicensee’s intention to bring or participate in a Licensed Patent Right Challenge. [[Organization A:Organization]] shall also provide to [[Agenus:Organization]] a complete written disclosure of each and every basis then known to [[Organization A:Organization]] or any [[Organization A:Organization]] Affiliate or Sublicensee for the Licensed Patent Right Challenge and shall provide [[Agenus:Organization]] with a copy of any document or publication that [[Organization A:Organization]] or any [[Organization A:Organization]] Affiliate or Sublicensee may use in connection with the Licensed Patent Right Challenge. [[Organization A:Organization]]’s failure to comply with this provision will constitute a material breach of this Agreement. If a claim of a Licensed Patent Right is adjudged to be not invalid by a governmental authority of competent jurisdiction, the Royalty rates and Sublicense Income payments due [[Agenus:Organization]] under this Agreement will be doubled with respect to Net Sales of Licensed Products occurring and sublicenses executed on or after the initiation of the Licensed Patent Right Challenge.

Licensed Patent Rights. All Licensed Patent Rights as of the Effective Date are listed in [Schedule 1.75] (Licensed Patents). Lyra is the sole and exclusive owner of the Licensed Patent Rights, all of which are free and clear of any claims, liens, charges or encumbrances. All Licensed Patent Rights have been filed and Prosecuted in good faith in the patent offices in accordance with applicable Laws, and all applicable fees have been paid on or before the due date for payment. All issued Licensed Patent Rights are valid and, to Lyra’s knowledge, subsisting and enforceable.

Enanta Licensed Patent Rights. All Licensed Patent Rights are existing and, to Enanta’s Knowledge, no Licensed Patent Rights are invalid or unenforceable.